Maetzold Derek J's Form 4 filing
Castle Biosciences Inc (CSTL) · filed Oct 26, 2022
- Accession no.
- 0001447362-22-000164
- Filed
- Oct 26, 2022
- Trade date
- Oct 24-25, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 14 non-derivative transactions. Open-market sales total $183.3K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Maetzold Derek JCIK 0001239501 | Director, Officer (Pres. & Chief Exec. Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 24, 2022 | Common Stock | SSaleDisposed | −3,483 | $20.41F2 | −$71,088.03 | 296,572 | Direct | |
| Oct 24, 2022 | Common Stock | SSaleDisposed | −1,704 | $20.41F2 | −$34,778.64 | 132,874 | Indirect | |
| Oct 24, 2022 | Common Stock | SSaleDisposed | −1,590 | $20.41F2 | −$32,451.9 | 121,134 | Indirect | |
| Oct 24, 2022 | Common Stock | SSaleDisposed | −341 | $20.41F2 | −$6,959.81 | 27,008 | Indirect | |
| Oct 24, 2022 | Common Stock | SSaleDisposed | −341 | $20.41F2 | −$6,959.81 | 27,006 | Indirect | |
| Oct 24, 2022 | Common Stock | SSaleDisposed | −341 | $20.41F2 | −$6,959.81 | 27,006 | Indirect | |
| Oct 24, 2022 | Common Stock | SSaleDisposed | −341 | $20.41F2 | −$6,959.81 | 27,001 | Indirect | |
| Oct 25, 2022 | Common Stock | SSaleDisposed | −350 | $20.98F9 | −$7,343 | 296,222 | Direct | |
| Oct 25, 2022 | Common Stock | SSaleDisposed | −171 | $20.98F9 | −$3,587.58 | 132,703 | Indirect | |
| Oct 25, 2022 | Common Stock | SSaleDisposed | −160 | $20.98F9 | −$3,356.8 | 120,974 | Indirect | |
| Oct 25, 2022 | Common Stock | SSaleDisposed | −34 | $20.98F9 | −$713.32 | 26,974 | Indirect | |
| Oct 25, 2022 | Common Stock | SSaleDisposed | −34 | $20.98F9 | −$713.32 | 26,972 | Indirect | |
| Oct 25, 2022 | Common Stock | SSaleDisposed | −34 | $20.98F9 | −$713.32 | 26,972 | Indirect | |
| Oct 25, 2022 | Common Stock | SSaleDisposed | −34 | $20.98F9 | −$713.32 | 26,967 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
This transaction was executed in multiple trades at prices ranging from $20.250 to $20.725, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 7 transactions in Table I.
- F9
This transaction was executed in multiple trades at prices ranging from $20.870 to $21.260, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 7 transactions in Table I.